Does RILPIVIRINE Cause Lung neoplasm malignant? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Lung neoplasm malignant have been filed in association with RILPIVIRINE (EDURANT). This represents 0.1% of all adverse event reports for RILPIVIRINE.
6
Reports of Lung neoplasm malignant with RILPIVIRINE
0.1%
of all RILPIVIRINE reports
4
Deaths
3
Hospitalizations
How Dangerous Is Lung neoplasm malignant From RILPIVIRINE?
Of the 6 reports, 4 (66.7%) resulted in death, 3 (50.0%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RILPIVIRINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RILPIVIRINE Cause?
Product dose omission issue (702)
Injection site pain (640)
Viral load increased (455)
Virologic failure (404)
Pathogen resistance (323)
Pain (297)
Off label use (274)
Product use in unapproved therapeutic environment (234)
Viral mutation identified (211)
Blood hiv rna increased (205)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which RILPIVIRINE Alternatives Have Lower Lung neoplasm malignant Risk?
RILPIVIRINE vs RILUZOLE
RILPIVIRINE vs RIMABOTULINUMTOXINB
RILPIVIRINE vs RIMEGEPANT
RILPIVIRINE vs RIOCIGUAT
RILPIVIRINE vs RIPRETINIB